A pharmacist shall review the patient's record when a prescription drug order or refill request is presented for dispensing in order to identify:
- (1) Overutilization, or use of a drug in quantities or for durations that put the patient at risk of an adverse drug reaction;
- (2) Underutilization, or use of a drug by a patient in an insufficient quantity to achieve a desired therapeutic goal;
- (3) Therapeutic duplication, or use of two or more drugs from the same therapeutic class in a way that the combined daily dose puts the patient at risk of an adverse drug reaction;
- (4) Drug-disease contraindications, or the potential for or the occurrence of an undesirable alteration of the therapeutic effect of a given drug because of the presence of a disease condition in the patient or an adverse effect of the drug on the patient's disease condition;
- (5) Adverse drug-drug interactions, or the potential for or the occurrence of an adverse drug reaction as a result of the patient using two or more drugs together;
- (6) Incorrect drug dosage, or the dosage lies outside the daily dosage range specified in the manufacturer's package insert for the drug as necessary to achieve therapeutic benefit;
- (7) Incorrect duration of drug treatment, or the number of days of prescribed therapy exceeds or falls short of the recommendations contained in the manufacturer's package insert for the drug;
- (8) Drug-allergy interactions, or the significant potential for or the occurrence of an allergic reaction as a result of drug therapy; or
(9) Clinical abuse or misuse.
The pharmacist shall attempt to avoid or resolve any problems identified during the review and may consult with the prescriber.
Source: 19 SDR 93, effective December 31, 1992 ; 50 SDR 138, effective June 2, 2024 .
General Authority: SDCL 36-11-68 .
Law Implemented: SDCL 36-11-2.2 , 36-11-68 .
Prior versions effective: 1992-12-31.